Brimonidine (topical)
INCI: Brimonidine
Topical alpha-2 adrenergic agonist for rosacea erythema. Constricts superficial vessels and removes redness for 9–12 hours.
Soothing
Evidence by route
Topical application
AProven efficacy. Two or more independent RCTs with instrumental endpoints.
The effect stays symptomatic and does not cure rosacea, only removes redness temporarily. A common issue is rebound erythema after withdrawal or overdose.
Tolerability and safety
Irritation potential
LowAllergen risk
LowPregnancy
CautionFrequently asked questions
Is Brimonidine (topical) safe during pregnancy?
Brimonidine (topical) should be used with caution during pregnancy. Consulting a dermatologist or OB-GYN is advisable.